Ischemic heart disease Board decisions

The Board granted service connection for ischemic heart disease (IHD) on a direct or facts-found basis, based on the Veteran's exposure to herbicides during his service at U-Tapao RTAFB in Thailand.

The Board granted service connection for ischemic heart disease and diabetes mellitus, type II, for accrued benefits purposes based on the Veteran's exposure to herbicide agents during his active service.

The Board granted service connection for COPD, bladder cancer, and a heart condition due to in-service exposure to asbestos and lead paint.

The Board remands the claim for a heart condition, including ischemic heart disease, to correct pre-decisional duty-to-assist errors related to obtaining service treatment records and a VA examination.

The Board remands the claims for service connection for heart disability, diabetes mellitus, spinal stenosis, sleep apnea, and an acquired psychiatric disorder due to duty-to-assist errors.

The appeal for a higher rating for coronary artery disease prior to June 8, 2016 and after June 8, 2016 was dismissed. The veteran was granted a 60 percent rating for obstructive sleep apnea with asthma from June 8, 2016 to September 15, 2021, but denied a higher rating since September 16, 2021.

The Veteran's earlier effective date for service connection for ischemic heart disease to include arteriosclerotic heart disease and hypertensive heart disease was granted, while a separate disability rating for hypertensive heart disease was denied.

The Board remands the claim for special monthly compensation based on aid and attendance due to a pre-decisional duty to assist error.

The Board granted service connection for coronary artery disease as secondary to hypertension but denied an earlier effective date and a higher rating for hypertension.

The Board denied the veteran's claims for earlier effective dates and remanded two issues for further development.

The Board denied service connection for multiple joint arthritis, heart disease, and memory loss. The Veteran's claims were not supported by sufficient evidence of in-service injury or disease.

The Board denied service connection for hypertensive heart disease as there is no current diagnosis of the condition.

The Board granted service connection for a bilateral foot disability but denied service connection for bilateral eye condition/pain and heart condition.

The Board remands the claims for service connection for asthma, cataracts, congestive heart failure, low back pain, and bilateral lower extremity radiculopathy due to a duty to assist error related to lost or destroyed service treatment records.

The Board remands the claims for service connection for chronic edema, right leg also claimed as pain and palpitations now claimed as tachycardia, heart condition, and mitral valve prolapse due to inadequate VA examinations.

The Board granted an effective date of June 27, 2022, for the award of service connection for coronary artery disease based on the Blue Water Navy Vietnam Veterans Act of 2019.

The Board granted the appeal and restored service connection for coronary artery disease with stable angina status post stent placement effective July 1, 2024.

The Board granted service connection for ischemic heart disease on a presumptive basis due to the Veteran's presumed exposure to herbicide agents during his service in Vietnam. The appeal of service connection for residuals of a cerebrovascular accident with hypertension was remanded for further development.

The Board denied service connection for the Veteran's cause of death, finding no evidence that his coronary artery disease was incurred or aggravated during active duty.

The appeal of the issue of entitlement to service connection for a heart disability was dismissed, while the claim for adenocarcinoma of the lung was granted.